11.01.2011

Polyoxidonium®, an effective and safe immunomodulator with a combination of pharmacological properties, now has new storage temperature requirements.

This unique drug, developed and manufactured by Petrovax Group, has been successfully used in clinical practice for 15 years.

Starting December 2010, from series 220610 (Registration Certificate Р№002 935/04-050510) on, the recommended temperature range for Polyoxidonium® in 12 mg tablets changed to 4–250С.

Packages of Polyoxidonium® in 12 mg tablets can be stored at room temperature, making them easier to transport and use, while maintaining the consistently high effectiveness and safety of this product.


Back to the list

© Petrovax
The materials posted on the site are for informational purposes only and are not intended to advertise or promote the manufacturer or medications produced.